Biological and biophysical principles in extracorporal bone tissue engineering Part I

被引:64
作者
Meyer, U [1 ]
Loos, U [1 ]
Wiesmann, HP [1 ]
机构
[1] Univ Munster, Dept Cranio Maxillofadal Surg, D-48149 Munster, Germany
关键词
bone tissue engineering; osteoblasts; cell stimulation;
D O I
10.1016/S0901-5027(03)00199-1
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Advances in the field of bone tissue engineering have encouraged physicians to introduce these techniques into clinical practice. Bone tissue engineering is the construction, repair or replacement of damaged or missing bone in humans or animals. Engineering of bone can take place within the animal body or extracorporal in a bioreactor for later grafting into the body. Appropriate cell types and non-living substrata are minimal requirements for an extracorporal tissue engineering approach. This review discusses the biological and biophysical background of in vitro bone tissue engineering. Biochemical and biophysical stimuli of cell growth and differentiation are regarded as potent tools to improve bone formation in vitro. The paper focuses on basic principles in extracorporal engineering of bone-like tissues, intended to be implanted in animal experiments and clinical studies. Particular attention is given in this part to the contributions of cell and material science to the development of bone-like tissues. Several approaches are at the level of clinical applicability and it can be expected that widespread use of engineered bone constructs will change the surgeon's work in the near future.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 113 条
[1]   An in vitro model for mineralization of human osteoblast-like cells on implant materials [J].
Ahmad, M ;
McCarthy, M ;
Gronowicz, G .
BIOMATERIALS, 1999, 20 (03) :211-220
[2]  
ALKHALDI A, 2001, EGF DEPENDENT ANGIOG, P11
[3]   Craniofacial tissue engineering [J].
Alsberg, E ;
Hill, EE ;
Mooney, DJ .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2001, 12 (01) :64-75
[4]  
Andrade J D, 1973, Med Instrum, V7, P110
[5]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[6]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[7]  
ASHTON BA, 1980, CLIN ORTHOP RELAT R, V32, P294
[8]  
Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.0.CO
[9]  
2-6
[10]  
BAGAMBISA FB, 1993, CELL MATER, V3, P93